From: Formulation and optimization of polymeric agglomerates of Bosentan monohydrate by crystallo-co-agglomeration technique
Batch
Talc (mg)
PEG6000 (mg)
Speed (RPM)
Particle size (µm) (Y1)
Angle of repose (Y2)
Drug content % (Y3)
Predicted
Actual
BOS 16
2.28
10
600
12.16
11.56 ± 0.89
30.48
30.33 ± 0.35
88.01
92.65 ± 0.215